|
1
|
Potapenko IO, Haakensen VD, Lüders T,
Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC and
Børresen-Dale AL: Glycan gene expression signatures in normal and
malignant breast tissue; possible role in diagnosis and
progression. Mol Oncol. 4:98–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pinho SS and Reis CA: Glycosylation in
cancer: Mechanisms and clinical implications. Nat Rev Cancer.
15:540–555. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Munkley J and Elliott DJ: Hallmarks of
glycosylation in cancer. Oncotarget. 7:35478–35489. 2016.PubMed/NCBI
|
|
4
|
Intra J, Perotti ME, Pavesi G and Horner
D: Comparative and phylogenetic analysis of alpha-L-fucosidase
genes. Gene. 392:34–46. 2007. View Article : Google Scholar
|
|
5
|
Fidler IJ: The pathogenesis of cancer
metastasis: The 'seed and soil' hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan K, Kucik D, Singh RK, Listinsky CM,
Listinsky JJ and Siegal GP: Alterations in human breast cancer
adhesion-motility in response to changes in cell surface
glycoproteins displaying α-L-fucose moieties. Int J Oncol.
32:797–807. 2008.PubMed/NCBI
|
|
8
|
Yuan K, Listinsky CM, Singh RK, Listinsky
JJ and Siegal GP: Cell surface associated alpha-L-fucose moieties
modulate human breast cancer neoplastic progression. Pathol Oncol
Res. 14:145–156. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Gu J, Ihara H, Miyoshi E, Honke K
and Taniguchi N: Core fucosylation regulates epidermal growth
factor receptor-mediated intracellular signaling. J Biol Chem.
281:2572–2577. 2006. View Article : Google Scholar
|
|
10
|
Beckerman R and Prives C: Transcriptional
regulation by p53. Cold Spring Harb Perspect Biol. 2:a0009352010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsutsumi-Ishii Y, Tadokoro K, Hanaoka F
and Tsuchida N: Response of heat shock element within the human
HSP70 promoter to mutated p53 genes. Cell Growth Differ. 6:1–8.
1995.PubMed/NCBI
|
|
12
|
Yamato K, Yamamoto M, Hirano Y and
Tsuchida N: A human temperature-sensitive p53 mutant p53Val-138:
Modulation of the cell cycle, viability and expression of
p53-responsive genes. Oncogene. 11:1–6. 1995.PubMed/NCBI
|
|
13
|
Ito T, Seyama T, Mizuno T, Tsuyama N,
Hayashi T, Hayashi Y, Dohi K, Nakamura N and Akiyama M: Unique
association of p53 mutations with undifferentiated but not with
differentiated carcinomas of the thyroid gland. Cancer Res.
52:1369–1371. 1992.PubMed/NCBI
|
|
14
|
Mackinnon WB, Delbridge L, Russell P, Lean
CL, May GL, Doran S, Dowd S and Mountford CE: Two-dimensional
proton magnetic resonance spectroscopy for tissue characterization
of thyroid neoplasms. World J Surg. 20:841–847. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsuchida N, Ikeda MA, Kanazawa S, Ishino
Y, Kaji K, Salvatore G and Vecchio G: Alpha-L-fucosidase (FUCA1) is
a p53 target gene, and is expressed at low levels in anaplastic
thyroid carcinomas. Int J Mol Med. 32(Suppl 1): S362013.
|
|
16
|
Ezawa I, Sawai Y, Kawase T, Okabe A,
Tsutsumi S, Ichikawa H, Kobayashi Y, Tashiro F, Namiki H, Kondo T,
et al: Novel p53 target gene FUCA1 encodes a fucosidase and
regulates growth and survival of cancer cells. Cancer Sci.
107:734–745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baudot AD, Crighton D, O'Prey J, Somers J,
Sierra Gonzalez P and Ryan KM: p53 directly regulates the
glycosidase FUCA1 to promote chemotherapy-induced cell death. Cell
Cycle. 15:2299–2308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sunde M, McGrath KC, Young L, Matthews JM,
Chua EL, Mackay JP and Death AK: TC-1 is a novel tumorigenic and
natively disordered protein associated with thyroid cancer. Cancer
Res. 64:2766–2773. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanaka J, Ogura T, Sato H and Hatano M:
Establishment and biological characterization of an in vitro human
cytomegalovirus latency model. Virology. 161:62–72. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gioanni J, Zanghellini E, Mazeau C, Zhang
D, Courdi A, Farges M, Lambert JC, Duplay H and Schneider M:
Characterization of a human cell line from an anaplastic carcinoma
of the thyroid gland. Bull Cancer. 78:1053–1062. 1991.In French.
PubMed/NCBI
|
|
21
|
Murugan AK, Hong NT, Fukui Y, Munirajan AK
and Tsuchida N: Oncogenic mutations of the PIK3CA gene in head and
neck squamous cell carcinomas. Int J Oncol. 32:101–111. 2008.
|
|
22
|
Liu J, Uematsu H, Tsuchida N and Ikeda MA:
Essential role of caspase-8 in p53/p73-dependent apoptosis induced
by etoposide in head and neck carcinoma cells. Mol Cancer.
10:952011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Romero-Calvo I, Ocón B, Martínez-Moya P,
Suárez MD, Zarzuelo A, Martínez-Augustin O and de Medina FS:
Reversible Ponceau staining as a loading control alternative to
actin in western blots. Anal Biochem. 401:318–320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Salvatore G, Nappi TC, Salerno P, Jiang Y,
Garbi C, Ugolini C, Miccoli P, Basolo F, Castellone MD, Cirafici
AM, et al: A cell proliferation and chromosomal instability
signature in anaplastic thyroid carcinoma. Cancer Res.
67:10148–10158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vecchio G, Parascandolo A, Allocca C,
Ugolini C, Basolo F, Moracci M, Strazzulli A, Cobucci-Ponzano B,
Laukkanen MO, Castellone MD and Tsuchida N: Human α-L-fucosidase-1
attenuates the invasive properties of thyroid cancer. Oncotarget.
View Article : Google Scholar : 2017.
|
|
26
|
Otero-Estévez O, Martínez-Fernández M,
Vázquez-Iglesias L, Páez de la Cadena M, Rodríguez-Berrocal FJ and
Martínez-Zorzano VS: Decreased expression of alpha-L-fucosidase
gene FUCA1 in human colorectal tumors. Int J Mol Sci.
14:16986–16998. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng TC, Tu SH, Chen LC, Chen MY, Chen
WY, Lin YK, Ho CT, Lin SY, Wu CH and Ho YS: Down-regulation of
α-L-fucosidase 1 expression confers inferior survival for
triple-negative breast cancer patients by modulating the
glycosylation status of the tumor cell surface. Oncotarget.
6:21283–21300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Krause A, Combaret V, Iacono I, Lacroix B,
Compagnon C, Bergeron C, Valsesia-Wittmann S, Leissner P, Mougin B
and Puisieux A: Genome-wide analysis of gene expression in
neuroblastomas detected by mass screening. Cancer Lett.
225:111–120. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Castellone MD and Vecchio G: RET and
Thyroid Carcinomas. Chromosomal Translocations and Genome
Rearrangements. Springer Publisher; pp. 357–380. 2015, View Article : Google Scholar
|
|
30
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takahashi M, Kuroki Y, Ohtsubo K and
Taniguchi N: Core fucose and bisecting GlcNAc, the direct modifiers
of the N-glycan core: Their functions and target proteins.
Carbohydr Res. 344:1387–1390. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kizuka Y and Taniguchi N: Enzymes for
N-Glycan branching and their genetic and nongenetic regulation in
cancer. Biomolecules. 6:pii: E25. 2016. View Article : Google Scholar : PubMed/NCBI
|
